ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RVNC Revance Therapeutics Inc

3.0481
-0.1119 (-3.54%)
May 21 2024 - Closed
Delayed by 15 minutes

Revance Therapeutics Financial Summary

The current RVNC market cap is 268.89M. The company's latest EPS is USD -3.6727 and P/E is -0.82.

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 49.92M49.33M58.13M56.78M69.8M
Operating Income -144.41M-58.03M-65.5M-139.29M-53.95M
Net Income -145.95M-59.79M-67.32M-141.18M-55.7M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 413k15.33M77.8M132.57M234.04M
Operating Income -164.46M-273.16M-274.68M-341.96M-316.78M
Net Income -159.43M-282.09M-281.31M-356.42M-323.99M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 581.9M547.8M597.54M532.49M478.45M
Total Liabilities 569.3M574.47M570.75M638.69M630.06M
Total Equity 12.6M-26.67M26.79M-106.2M-151.6M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 340.29M720.22M531.16M581.9M478.45M
Total Liabilities 114.8M345.93M462.69M569.3M630.06M
Total Equity 225.49M374.29M68.47M12.6M-151.6M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -193.55M-69.5M-122.88M-173.84M-216.58M
Investing -138.8M95.32M55.78M107.37M109.74M
Financing 331.69M3.27M100.74M138.2M136.57M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -106.16M-178.5M-221.54M-193.55M-216.58M
Investing -17.59M12.13M-29.67M-138.8M109.74M
Financing 221.66M331.48M29.87M331.69M136.57M
Market Cap 268.89M
Price to Earnings Ratio -0.82
Price to Sales Ratio 1.13
Price to Cash Ratio 1.93
Price to Book Ratio -1.75
Dividend Yield -

Share Statistics

Shares Outstanding 88.21M
Average Volume (1 week) 2.72M
Average Volume (1 Month) 2.4M
52 Week Change -90.44%
52 Week High 33.095
52 Week Low 2.90
Spread (Intraday) 0.04 (1.31%)

Company Info

Company Name Revance Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.revance.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock